Skip to content

buying

1 Buy, 2 Sells From One Of The Hottest Sectors

As investors attempt to identify the COVID-19 vaccine stock that will beat all the others, biotech has become one of the hottest sectors, with the S&P Biotech SPDR ETF having jumped nearly 80% since hitting its March low. Today’s article offers an analysis of three specific biotech stocks and insights on what to do with each if you are considering… 

CLICK HERE »1 Buy, 2 Sells From One Of The Hottest Sectors

This Under-The-Radar Biotech’s Only Drug Candidate Could Become “A Mega-Blockbuster”

While buying right now may be too risky for the average investor, the small-cap biotech highlighted in today’s article could be worth keeping an eye on, even as it (and many other promising biotech stocks) may have slipped under the radar as attention has shifted to potential COVID-19 plays (which this stock is not). Why? The company’s drug candidate for… 

CLICK HERE »This Under-The-Radar Biotech’s Only Drug Candidate Could Become “A Mega-Blockbuster”